Makary committed to a review of the drug in a letter responding to Sen. Josh Hawley’s (R-MO) concerns about mifepristone, following a the release of a new study suggesting real-world complications from the pill are 22 times higher than what is listed on the FDA-approved drug label. …
Read More
